Xiaoqing Fan
Luzhou, 646000, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 10 publications
Epigallocatechin-3-gallate ameliorates LPS-induced ARDS by modulating Akkermansia-associated SCFAs metabolism and inhibiting the JAK2/STAT3 candidate signaling pathway.
Journal: Food & function
Published: March 10, 2026
PA-MSHA promotes antitumor immunity in STK11 mutant NSCLC through activating the STING pathway of immune cells.
Journal: International immunopharmacology
Published: January 21, 2026
Epigallocatechin Gallate Influences in Acute Respiratory Distress Syndrome by Regulating Gut Microbiota: Current Research Status and Therapeutic Prospects.
Journal: Journal of inflammation research
Published: July 28, 2025
The miR-23a/27a/24-2 cluster promotes postoperative progression of early-stage non-small cell lung cancer.
Journal: Molecular therapy oncolytics
Published: June 16, 2021
The Human Positive Cofactor 4 is a Promising Chemotherapeutic Target in Lung Adenocarcinoma.
Journal: Journal of oncology
Published: March 08, 2021
FOXO1 and FOXO3a sensitize non-small-cell lung cancer cells to cisplatin-induced apoptosis independent of Bim.
Journal: Acta biochimica et biophysica Sinica
Published: March 08, 2020
Image Representation Method Based on Relative Layer Entropy for Insulator Recognition.
Journal: Entropy (Basel, Switzerland)
Published: March 02, 2020
Catanionic lipid nanosystems improve pharmacokinetics and anti-lung cancer activity of curcumin.
Journal: Nanomedicine : nanotechnology, biology, and medicine
Published: September 23, 2015
Evodiamine induces G2/M arrest and apoptosis via mitochondrial and endoplasmic reticulum pathways in H446 and H1688 human small-cell lung cancer cells.
Journal: PloS one
Published: May 07, 2014
Showing 1-10 of 10
Last Updated: 09/26/2026